News

Partner companies' news

KemPharm to Participate in BIO Partnering @ JPM During “J.P. Morgan Week 2022”
CELEBRATION, Fla., Jan. 06, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 486 views KMPH

KemPharm, Inc. Announces Authorization of $50 Million Share Repurchase Program
CELEBRATION, Fla., Dec. 20, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— December 2021 — 516 views KMPH

KemPharm, Inc. Announces Top-Line Results from Clinical Trial Evaluating the Safety and Pharmacokinetics of “Higher-Dose SDX”
CELEBRATION, Fla., Dec. 14, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and ...
Acorn Management Partners, Administrator
— December 2021 — 474 views KMPH

KemPharm Named 2021 David J. Gury Company of the Year by BioFlorida
CELEBRATION, Fla., Dec. 13, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and ...
Acorn Management Partners, Administrator
— December 2021 — 516 views KMPH

Luokung Announces Interim Results for the Three and Nine Months Ended September 30, 2021, Reports Record Revenue of $74.9 Million for the Nine-Month Period
BEIJING, Dec. 2, 2021 /PRNewswire/ -- *Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company")*, a leading spatial-temporal intelligent...
Acorn Management Partners, Administrator
— December 2021 — 451 views LKCO

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives